NAFLD/NASH Education Series

NASH Trend Alerts: Q2 2021 by NASHNET

Join Dr. Amreen Dinani (Mount Sinai Icahn School of Medicine) and Dr. Michelle Long (Boston Medical Center) as they discuss current updates and trends relating to NAFLD/NASH. Topics include the impact of COVID-19 on NAFLD/NASH care delivery, emerging trends in virtual care, and innovative provider education initiatives. NASH Trend Alerts is a quarterly podcast series supported by NASHNET, a global network of liver Centers of Excellence dedicated to improving NAFLD/NASH care delivery. Learn more about NASHNET on www.nashnetwork.org.

Join our host, Dr. Amreen Dinani, as we discuss an often undetected liver disease affecting up to 25% of the world's population: nonalcoholic fatty liver disease (NAFLD)and its more severe form, nonalcoholic steatohepatitis(NASH). Each episode, Dr. Dinani is joined by hepatologists from across the United States to talk about the importance of early identification, available diagnostics, and existing and emerging treatments. Whether you're a patient, healthcare professional, or payer, we hope you can join us and learn something new. Learn more at www.nashnetwork.org. In celebration of International NASH Day on June 12th, NASHNET is releasing a special patient story bonus episode. In this episode, Dr. Dinani interviews a patient advocate on her experience being diagnosed with NAFLD/NASH. Listeners will learn more about NASH care pathways from the patient perspective and patient-centered resources for NASH care management.

Join our host, Dr. Amreen Dinani, as we discuss an often undetected liver disease affecting up to 25% of the world's population: nonalcoholic fatty liver disease (NAFLD)and its more severe form, nonalcoholic steatohepatitis(NASH). Each episode, Dr. Dinani is joined by hepatologists from across the United States to talk about the importance of early identification, available diagnostics, and existing and emerging treatments. Whether you're a patient, healthcare professional, or payer, we hope you can join us and learn something new. Learn more at www.nashnetwork.org. Episode 3 features Dr. Dinani and Dr. Sussman, a hepatologist at Baylor College of Medicine, discussing existing and emerging treatments for NAFLD and NASH. Listeners will learn more about strategies to manage NAFLD and NASH patients and encourage sustainable behaviors, emerging treatment options, and considerations for provider and patient education.

Join our host, Dr. Amreen Dinani, as we discuss an often undetected liver disease affecting up to 25% of the world's population: nonalcoholic fatty liver disease (NAFLD)and its more severe form, nonalcoholic steatohepatitis(NASH). Each episode, Dr. Dinani is joined by hepatologists from across the United States to talk about the importance of early identification, available diagnostics, and existing and emerging treatments. Whether you're a patient, healthcare professional, or payer, we hope you can join us and learn something new. Learn more at www.nashnetwork.org. Episode 2 features Dr. Dinani and Dr. Fuchs, a hepatologist at the Hunter Holmes McGuire VA Medical Center, discussing NASH diagnostics. Listeners will learn more about non-invasive testing for NASH, care pathways, barriers to use, how primary care providers can get involved, and more.

Join our host, Dr. Amreen Dinani, as we discuss an often undetected liver disease affecting up to 25% of the world's population: nonalcoholic fatty liver disease (NAFLD)and its more severe form, nonalcoholic steatohepatitis(NASH). Each episode, Dr. Dinani is joined by hepatologists from across the United States to talk about the importance of early identification, available diagnostics, and existing and emerging treatments. Whether you're a patient, healthcare professional, or payer, we hope you can join us and learn something new. To learn more, visit https://www.nashnetwork.org/.